Volume 8, Issue 1 (3-2020)
Jorjani Biomed J 2020, 8(1): 4-10 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
jafari-sales A, Khaneshpour H, Pashazadeh M, Nasiri R. Coronavirus Disease 2019 (COVID-19): review study. Jorjani Biomed J 2020; 8 (1) :4-10
URL: http://goums.ac.ir/jorjanijournal/article-1-688-en.html
URL: http://goums.ac.ir/jorjanijournal/article-1-688-en.html
1- Department of Microbiology School of Basic Sciences, Kazerun Branch, Islamic Azad University, Kazerun, Iran , a.jafari_1392@yahoo.com
2- Department of Microbiology, Ahar Branch, Islamic Azad University, Ahar, Iran
3- Department of Immunology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey
4- Iran National Elite Foundation, Tehran 93111-14578, Iran
2- Department of Microbiology, Ahar Branch, Islamic Azad University, Ahar, Iran
3- Department of Immunology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey
4- Iran National Elite Foundation, Tehran 93111-14578, Iran
Abstract: (5051 Views)
On December 31, 2019, the Wuhan-China Health Commission reported a case of pneumonia in the city. The first symptoms began in mid-December 2019. Clinically isolated specimens identified the coronavirus as the cause of the disease. It was first shown as 2019-nCoV, and as the number of victims of the coronavirus crossed the border of thousands of people, the World Health Organization chose the official name COVID-19 for its illness. Although it appears to be of animal origin, it is rapidly transmitting from person to person around the world. The World Health Organization released a statement calling the outbreak of the new Corona virus a Public Health Emergency Situations that poses a threat to the whole world, not just China. In this study highlights how the virus is transmitted, the clinical signs, the laboratory characteristics, the pathogenicity of the virus, Vaccines, and the prevention and control of the spread of the virus.
Type of Article: Review Article |
Subject:
Basic Medical Sciences
Received: 2020/01/5 | Accepted: 2020/02/29 | Published: 2020/03/1
Received: 2020/01/5 | Accepted: 2020/02/29 | Published: 2020/03/1
References
1. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. Journal of Medical Virology. 2020;92(4):424-32. [view at publisher] [DOI] [Google Scholar]
2. David JK, Salvatore R. Fear of the novel coronavirus. The Journal of Infection in Developing Countries. 2020;14(01). [view at publisher] [DOI] [Google Scholar]
3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020;382(8):727-33. [DOI] [Google Scholar]
4. Vahdat K, Amini A, Najafi A, Haerinejad MJ. A Review of Novel Coronavirus, cause of Middle East Respiratory Syndrome. Iranian South Medical Journal. 2014;16(6):486-92. [view at publisher] [Google Scholar]
5. Lai CC, Shih TP, Ko WC, et al. Severe Acute Respiratory Syndrome Coronavirus 2(SARS Cov-2) And Corona Virus Disease-2019(COVID-19): The Epidemic And The Challenges. Int J Antimicrob Agents (In press)2020; 105924 [view at publisher] [DOI] [Google Scholar]
6. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus-The species and its viruses, a statement of the Coronavirus Study Group. BioRxiv. 2020. [view at publisher] [Google Scholar]
7. National Health Commission's briefing on the pneumonia epidemic situation. Released on 23 Feb 2020.
8. Masters PS. Coronavirus genomic RNA packaging. Virology. 2019;537:198-207. [view at publisher] [DOI] [Google Scholar]
9. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochemical and Biophysical Research Communications. 2020;in press (
https://doi.org/10.1016/j.bbrc.2020.02.071 [view at publisher] [DOI] [Google Scholar]
10. Ralph R, Lew J, Zeng T, Francis M, Xue B, Roux M, et al. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. Journal of infection in developing countries. 2020;14(1):3-17. [view at publisher] [DOI] [Google Scholar]
11. Ghanei M., Karami A., Hosseinidost S. R., Abolghasemi H., Hosseini S. M. J. Severe acute respiratory syndrome(Sars). Journal of Military Medicine. 2003;4(4):265-72. [view at publisher] [Google Scholar]
12. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. The New England journal of medicine. 2003;348(20):1953-66. [view at publisher] [DOI] [Google Scholar]
13. Bleibtreu A, Jaureguiberry S, Houhou N, Boutolleau D, Guillot H, Vallois D, et al. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016. BMC Infectious Diseases. 2018;18(1):331. [view at publisher] [DOI] [Google Scholar]
14. Riza S, ErdoganAysegul, AgaogluPelin M, DineriYeliz, Yusuf C, SenelMahmut E, et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO. 2020;4(1):1-7. [Google Scholar]
15. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020.
16. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;6736(20):30360-3. [view at publisher] [DOI] [Google Scholar]
17. Deng S, Peng H-J. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. Journal of Clinical Medicine. 2020;9(2):575. [view at publisher] [DOI] [Google Scholar]
18. Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes and Infection. 2020;in press (
https://doi.org/10.1016/j.micinf.2020.01.004 [view at publisher] [DOI] [Google Scholar]
19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020;395(10223):507-13. [view at publisher] [DOI] [Google Scholar]
20. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497-506. [view at publisher] [DOI] [Google Scholar]
21. Chang L, Yan Y, Wang L. Coronavirus Disease 2019: Coronaviruses and Blood Safety. Transfusion Medicine Reviews. 2020;in press(
https://doi.org/10.1016/j.tmrv.2020.02.003 [view at publisher] [DOI] [Google Scholar]
22. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019;17(3):181-92. [view at publisher] [DOI] [Google Scholar]
23. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience trends. 2020;in press(DIO: 10.5582/bst.2020.01047. [DOI] [Google Scholar]
24. Lim J, Jeon S, Shin HY, et al. Case Of The Index Patient Who Caused Tertiary Transmission Of Coronavirus Disease 2019 In Korea: The Application Of Lopinavir/Ritonavir For The Treatment Of COVID-19 Pneumonia Monitored By Quantitative RT-PCR. J Korean Med Sci 2020; 35(6): e79. [view at publisher] [DOI] [Google Scholar]
25. Mulangu S, Dodd LE, Davey Jr RT, et al. A Randomized, Controlled Trial Of Ebola Virus Disease Therapeutics. New Engl J Med 2019; 381(24): 2293-303. [view at publisher] [DOI] [Google Scholar]
26. Wang F-S, Zhang C. What to do next to control the 2019-nCoV epidemic? The Lancet. 2020;395(10222):391-3. [view at publisher] [DOI] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
